CLMT

In the past six months, Calumet reported a fiscal year 2025 net loss of $33.8 million and Adjusted EBITDA with Tax Attributes of $293.3 million, also announcing $222 million of recourse debt reduction in 2025. Calumet completed an offering of $150 million of additional 9.75% Senior Notes due 2031, using the proceeds to redeem outstanding notes and amended its ABL facility to extend its maturity date to January 2031. Calumet reported a Q1 2026 GAAP loss of $3.64 per share, missing consensus estimates, but revenue of $1.03 billion beat expectations. Analyst ratings and price targets varied, with HC Wainwright boosting its price target and Goldman Sachs Group lowering its rating. Calumet, Inc. has seen a significant increase of 181.40% in its stock price over the last year.